Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sandra Nusinoff-Lehrman"'
Autor:
Gary Fahle, Robin K. Avery, Debra Birnkrant, Jeffrey C. Murray, Yoshihiko Murata, Mary Singer, Randi Y. Leavitt, Hans H. Hirsch, Lynn Fallon, Francisco Martinez-Murillo, John E. McKinnon, Gavin Cloherty, Randall Lanier, Rekha Abichandani, Philip R. Krause, Sally Mossman, M Michelle Berrey, Wael Saber, Ali Alghamdi, John A. D. Leake, Raymund R. Razonable, Takashi E. Komatsu, Emily A. Blumberg, Mahmood Tazari, Kurt Gunter, Thomas Mertens, Jens D Lundgren, Yoichiro Natori, Sunwen Chou, Kevin Modarress, Jay Erdman, Li Li, Terry Bowlin, Peter W. Hunt, William Cruikshank, Anna Wijatyk, Frank Kuhr, Garrett Nichols, Aimee Hodowanec, Marcie L. Riches, Shahid Husain, Karl S. Peggs, Jules O'Rear, Johann Mols, Filip Josephson, Christopher Lademacher, Paul Baum, Bernhardt Zeiher, Paul D. Griffiths, Susan Barnett, Mark N. Prichard, Michael Boeckh, Roy F. Chemaly, Megan McCutcheon, Thomas Stamminger, Fausto Baldanti, Chalom Sayada, Veronica Miller, Andreas Pikis, Atul Humar, Dimitri Gonzalez, Barbara D. Alexander, Jennifer Brooks, Jeff Roberts, Camille N. Kotton, Hermann Einsele, Tadd Lazarus, David Boutolleau, Deepali Kumar, Sandra Nusinoff Lehrman, Ani Orchanian-Cheff, Howard Mayer, Heather Gillis, Dong Yu, David Murawski, Per Ljungman, Paula Isabelle Lodding, Lesia K. Dropulic
Publikováno v:
Clinical Infectious Diseases. 66:617-631
Symptomatic cytomegalovirus (CMV) disease has been the standard endpoint for clinical trials in organ transplant recipients. Viral load may be a more relevant endpoint due to low frequency of disease. We performed a meta-analysis and systematic revie
Autor:
Betty J. Dong, Francesca T. Aweeka, Sandra Nusinoff Lehrman, James McIntyre, Christine Kaseba, Elias K. Halvas, Arrow trial team, John W. Mellors, Thomas B. Campbell, E. Halvas, Daniel R. Kuritzkes, Carolyn Wester, Heather Watts, Michael Hughes, Monica Carten, Sandra Rwambuya, Shahin Lockman, Beth Zwickl, Valerie F. Boltz, John M. Coffin, Beverly Putnam, Scott M. Hammer, Yajing Bao, Mary A. Marovich, Ian Sanne, Robin DiFrancesco, CissyKityo Mutuluuza, Robert T. Schooley, William C. Holmes, Charles C. Maponga, Cheryl Marcus, Annie Beddison, Jane Hitti, Peter Ndhleni Ziba, Michael S. Saag, Mary F. Kearney, Lynn Kidd-Freeman, Peter Mugyenyi
Publikováno v:
The Journal of Infectious Diseases. 209:703-710
Mutations in the human immunodeficiency virus type 1 (HIV-1) genome have been hypothesized to occur at all nucleotide positions, including those that confer drug resistance, as the result of high rates of HIV-1 replication, mutation, and recombinatio
Autor:
Daniel F. Hoth, Dianne M. Finkelstein, Sandra Nusinoff-Lehrman, Henry S. Sacks, Susan S. Ellenberg, James Eigo, Ellen C. Cooper
Publikováno v:
Controlled Clinical Trials. 13:272-292
Autor:
Ross E. McKinney, Philip A. Pizzo, Gwendolyn B. Scott, Wade P. Parks, Mary A. Maha, Sandra Nusinoff Lehrman, Mike Riggs, Jane Eddy, Barbara A. Lane, Stephen C. Eppes, Catherine M. Wilfert, null Pediatric Zidovudine Phase I Study Group
Publikováno v:
The Journal of Pediatrics. 116:640-647
Thirty-five children with symptomatic human immunodeficiency virus infection were enrolled in a 12-week, three-center phase I study of intravenous and oral zidovudine therapy. At enrollment the children ranged in age from 5 months to 13 years, with a
Autor:
Stephen E. Mahoney, John D. Reveille, Madeleine Duvic, Marcus A. Conant, Sandra Nusinoff Lehrman, Martin M. Crane
Publikováno v:
Archives of Dermatology. 130:447
Background and Design: Patients with human immunodeficiency virus (HIV) infection can develop severe psoriasis, which is difficult to treat using conventional therapy. Anecdotal case reports have suggested that administration of zidovudine can improv
Autor:
M. Robert Slum, Harry Hollander, Mary Maha, George W. Rutherford, Alan R. Lifson, Sandra Nusinoff-Lehrman
Publikováno v:
The American Journal of Medicine. 87:628-632
Purpose The combination of zidovudine and acyclovir has shown in vitro antiretroviral activity and led to short-term improvement in patients with symptomatic human immunodeficiency disease (HTV) disease. We performed a phase I study of zidovudine (50
Publikováno v:
The Pediatric Infectious Disease Journal. 2:333-341
Publikováno v:
Nature. 323:467-469
The retroviruses human T-cell lymphotrophic virus-I (HTLV-I)1,2 and HTLV-III/LAV (lymphadenopathy-associated virus)3,4 are clearly linked to human diseases. Patients with HTLV-I-positive neoplasms may respond transiently to traditional chemotherapy,
Autor:
Sandra Nusinoff Lehrman
Publikováno v:
Principles of Medical Therapy in Pregnancy ISBN: 9781461294719
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ba8f922616da1333a677fd7082620e6
https://doi.org/10.1007/978-1-4613-2415-7_79
https://doi.org/10.1007/978-1-4613-2415-7_79
Autor:
Sandra Nusinoff Lehrman, David W. Barry, Sharon E. Straus, M. Nixon Ellis, James F. Rooney, Edgar L. Hill
Publikováno v:
The Journal of antimicrobial chemotherapy. 18
The in-vitro sensitivity of herpes simplex virus isolated from patients enrolled in clinical trials of orally administered chronic suppressive acyclovir therapy was determined. Approximately 500 isolates from 250 patients were examined. There was no